Recap: The Value of Achieving Remission in Inflammatory Rheumatic Diseases
Last month, the Global Alliance for Patient Access participated in a meeting on the value of achieving remission in inflammatory rheumatic diseases.
Resumen: el valor de lograr la remisión en las enfermedades reumáticas inflamatorias
El mes pasado, la Alianza Global para el Acceso de los Pacientes participó en una reunión sobre el valor de lograr la remisión de las enfermedades reumáticas inflamatorias.
Prioritizing Heart Health on World Heart Day
World’s first evidence glossary quantifies the impact of inflammatory rheumatic conditions
The Global Alliance for Patient Access has launched the Value of Achieving Remission in Inflammatory Rheumatic Conditions Glossary, providing a full picture of the clinical, social and economic impact of the conditions for the first ever time.
Make the Change for Kidney Health
Chronic kidney disease – CKD – poses a growing burden across the globe. CKD affects more than 10% of the world’s population, or approximately 850 million people, and is projected to be the world’s fifth leading cause of death by 2040. Yet it’s not considered a priority among non-communicable diseases.
Kidney Health for All
Chronic kidney disease affects more than 10% of the world’s population, around 850 million people. World Kidney Day aims to bring that number down – by raising awareness, advancing screening and improving access to treatment.
Illuminating Advocacy: Rare Disease Day
February 29 unites more than 300 million people worldwide who share a common challenge: living with a rare disease.
New Global Patient Alliance Is Raising Profile of Chronic Kidney Disease
A new global coalition, the Global Patient Alliance for Kidney Health, launched last week. With 17 member organizations spanning five continents, the Alliance hopes to improve screening access and early treatment for a serious but often neglected public health challenge: chronic kidney disease, or CKD.
New Kidney Health Alliance Elevates Chronic Kidney Disease on Global Health Agenda
Seventeen patient advocacy organizations from North and South America, Europe, Asia and the Middle East have formed the Global Patient Alliance for Kidney Health. The Alliance aims to elevate patient voices and advocate for policies that enhance access to screening and early treatment of chronic kidney disease, or CKD.
Novo Projeto de Lei Mostra Promessa para Ensaios Clínicos no Brasil
Com a participação girando em torno de 2%, os ensaios clínicos no Brasil enfrentam desafios reais. Por isso, públicos interessados estão se unindo para entender o motivo disso – e encontrar soluções políticas.
